Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
316
Views
49
CrossRef citations to date
0
Altmetric
Review

Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis

Veena Mathew1 Department of Neurology, UCI ALS and Neuromuscular Center, University of California, Irvine, Orange, CA, USA, [email protected]
&
Annabel K Wang1 Department of Neurology, UCI ALS and Neuromuscular Center, University of California, Irvine, Orange, CA, USA, [email protected];2 Neurology Section, Tibor Rubin VA Medical Center, Long Beach, CA, USA, [email protected]Correspondence[email protected]
Pages 1515-1525 | Published online: 06 May 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.